Like the year before it, 2021 has been dominated by the global fight against coronavirus.
Over the last two years, there has been an unprecedented frenzy to develop new vaccines due to the COVID-19 pandemic, but DNA vaccines have rather stood in the shadow of their mRNA cousins.
As India nears the rollout of ZyCoV-D, the world’s first DNA-based, needle-free Covid vaccine for individuals aged 12 years and above, one Bengaluru trial site gave the low-down on how the much talked about jab works.
The ZyCoV-D vaccine heralds a wave of DNA vaccines for various diseases that are undergoing clinical trials around the world.
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.
On Friday, the Indian government authorized a needle-free Covid-19 vaccine developed by an indigenous pharmaceutical company.
New Delhi: A decision on the approval of Zydus Cadila’s COVID-19 vaccine Zydus Cov-D is expected soon…
Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot
ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group
The trial of a needle-free covid vaccine is now being tested on volunteers throughout Australia.